Precision Genomics.
Designed for Human Diversity.
We combine next-generation DNA sequencing with proprietary AI-driven interpretation to deliver clinical-grade, population-agnostic genetic insights.
Comprehensive exome sequencing enriched with mitochondrial DNA and curated non-coding markers, covering the most clinically relevant regions of the genome.
- >99% Coverage of genes
- Detection of rare, actionable mutations
- Built on Illumina sequencing
Why it matters: Focus on what's clinically relevant — without unnecessary noise.
Our proprietary ML engine ensures accurate results across ethnicities.
- 94.89% sensitivity in detection
- Unbiased ACMG classification
- Prioritises clinically meaningful findings
Why it matters: Most tests are less accurate outside Western populations. This isn't.
The reports are designed to drive preventive and clear clinical actions.
- Evidence backed genetic findings
- Clinically interpretable reports
- Enables early detection and preventive, precision care
Why it matters: Not just data — clear guidance you and your doctor can rely on.
The Future of Healthcare Starts From Your DNA.
Genetic diseases are often progressive and can be worsened by lifestyle or environmental factors. The future of healthcare lies in the ability to detect diseases at the DNA level, enabling targeted surveillance, preventive measures, and precise clinical intervention.
HEALTHSTRING analyses genetic factors associated with over 7,442 health conditions, including cancers, cardiovascular diseases, and many others.
HEALTHSTRING analyses cancer-causing genes and their mutations, offering the most comprehensive preventive cancer screening available globally. Covers organs including Breast, Lung, Blood, Thyroid, Stomach, Ovary, Prostate, Liver, Brain, Pancreas, Skin, Kidney, Colon, and more. Conditions include Lynch Syndrome, Li-Fraumeni Syndrome, Hereditary Breast-Ovarian Cancer, Hereditary Colorectal Cancer, Von Hippel-Lindau Syndrome, Retinoblastoma, and 182 more.
Choose the Right Medication. Personalised From Your DNA.
Your genes determine how your body metabolises drugs. The same dose that heals one person can cause serious harm to another. Healthstring screens across every major prescribing category.
We adhere to international guidelines, ensuring clinical accuracy.
Not All Genetic Tests Deliver The Same Answers.
Genetic testing has come a long way. Many tests today go beyond basic SNP markers. Some sequence your exome. Others, your whole genome. At first glance, they may look like HEALTHSTRING. They are not. The difference isn't just the technology. It's the depth, the clinical rigour, and whether the findings can truly guide your health decisions.
SNP chip sensitivity of <40% for rare pathogenic BRCA1/BRCA2 variants (Weedon et al., BMJ, 2021); polygenic risk score screening sensitivity of ~11% across 310 diseases (BMJ, 2023). HEALTHSTRING sensitivity of 94.89% is internally benchmarked.
You Will Never Have to Navigate Your Report Alone.
A genetic report can contain hundreds of data points: variants, risk flags, drug interactions, carrier statuses. Without the right guidance, even the most detailed report can feel overwhelming or easy to misinterpret.
That is why every HEALTHSTRING test includes a dedicated one-on-one session with a qualified genetic consultant. They will walk you through exactly what your results mean for your health, explain which findings need action, and give you a clear, personalised set of next steps, whether that is a lifestyle change, a targeted screening, or a referral to the right specialist.
You also get three months of follow-up support after your session, so any questions that arise as you digest your report have a place to go.
Your consultant explains every finding in plain language: what it means, what it does not mean, and what comes next.
Lifestyle adjustments, targeted screenings, or specialist referrals, tailored to your specific genetic profile.
Questions do not always come up in one sitting. Our team stays available for follow-up for three months after your session.
Our Clinical Partners
Your Insights Connect Directly to Medical Action.
Knowing your genetic risk is only meaningful if it leads somewhere. SugarStrings.ai has partnered with leading hospital networks, Narayana Health and Aster Medcity, so that your findings are not just filed away but acted upon.
If your report flags a risk that needs clinical follow-up, our network ensures you can reach the right specialist without having to start from scratch. Your genetic consultant will guide you on next steps and, where needed, connect you directly into our hospital partner network for targeted screenings, specialist consultations, or further diagnostics.
From DNA to diagnosis, the entire path is supported.
This test provides risk assessment and is not a diagnostic tool.
Please consult a qualified healthcare professional for medical decisions.